Law360 reports in “In Case You Missed It: Hottest Firms and Stories on Law360,” an article co-authored by Shook Houston Managing Partner Jennise Stubbs was one of the publication’s 10 most-read expert analyses in early July.
In “The Art of the ‘Science and Expert Team’ in Mass Torts,” Stubbs, with Adrienne Busby, Victoria Calhoon and Colleen Hennessey, discussed best practices for science-and-expert “virtual” law teams working in collaboration with other virtual team members in drug and device mass tort litigation. As they explain, virtual teams are “collaborative and often technology-based team of lawyers, each selected for specific tasks, to defend a single client’s litigation in the most efficient way.”
Science, and its integration into case strategy, is fundamental to every lawsuit involving pharmaceuticals and medical devices. The claims that plaintiffs assert, including product design, manufacturing and warnings are all scientific claims, the authors say. To develop experts and successfully convey accurate information to jurors, the science team plays a role in educating the trial team about particular topics, compiling key evidence and literature, and providing assessments of records and data.
Stubbs is a trial attorney who has represented Fortune 100 companies in the pharmaceutical and medical device, manufacturing, automotive, retail, professional, medical and service industries. Busby and Calhoon are partners at Faegre Baker Daniels LLP, and Colleen Hennessey is a partner at Peabody & Arnold LLP.